Current role
Biotechnology · Healthcare
Board Member
2025-02-06–present
Douglas Ingram
Board Member
Arrowhead Pharmaceuticals, Inc. (ARWR)Equibles does not estimate personal net worth.
Get an email with a short summary when Arrowhead Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARWR alertsAbout Douglas Ingram
Douglas Ingram is recorded as Board Member at Arrowhead Pharmaceuticals, Inc. (ARWR) since February 6, 2025. Arrowhead Pharmaceuticals, Inc. reported in an 8-K filed February 7, 2025 that Douglas Ingram was appointed director, effective February 6, 2025. Arrowhead Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arrowhead Pharmaceuticals, Inc. includes Christopher Anzalone (CEO and Board Member), Daniel Apel (CFO), Patrick O'Brien (COO) and 6 others.
“On February 5, 2025, the Board of Directors of Arrowhead Pharmaceuticals, Inc. (the “Company”) appointed Douglas Ingram as a director of the Company, effective February 6, 2025.”
Affiliation history
-
Current
2025-02-06–present
Company network
Leadership on record at Arrowhead Pharmaceuticals, Inc.
- Christopher Anzalone CEO, Board Member
- Daniel Apel CFO
- Patrick O'Brien COO
- Patrick O’Brien COO, General Counsel
- Dr. Matt Cohen, M.D., M.B.A. Board Member
- Hongbo Lu Board Member
- Hongbo Lu, Ph.D. Board Member
- Oye Olukotun, M.D., MPH Board Member
- Victoria Vakiener Board Member